The U.S. Department of Labor (DOL) has released a new model Employer CHIP Notice with information current as of Jan. 31, 2024.
As a reminder, the Children’s Health Insurance Program Reauthorization Act of 2009 (CHIPRA) imposes an annual notice requirement on employers that maintain group health plans in states that provide premium assistance subsidies under a Medicaid plan or a Children’s Health Insurance Plan (CHIP).
An employer is subject to this annual notice requirement if its group health plan covers participants who reside in a state that provides a premium assistance subsidy, regardless of the employer’s location.
The DOL’s model notice, which employers may use for this disclosure, is updated periodically to reflect changes in the states that offer premium assistance subsidies. The DOL’s model Employer CHIP Notice includes information current as of Jan. 31, 2024.
Employers could also choose to prepare their own notices or modify the model notice. Employers should be sure to include at least the minimum relevant state contact information for any employee residing in a state with premium assistance.
Contact us to see how you could minimize risk:
Recent News
H.R. 1 Expands HSA Eligibility
President Trump signed the “One Big Beautiful Bill Act” into law on 7/4. Learn how this impacts health plan offerings.
CVSA’s Brake Safety Week Scheduled for Aug. 24-30
The CVSA’s Brake Safety Week, set for Aug. 24-30, 2025, promotes brake system inspections, maintenance, and repairs to help prevent CMV accidents.
PCORI Fees Due July 31, 2025
The ACA requires health insurers and self-insured plan sponsors to pay annual PCORI fees, reported using IRS Form 720.
Seubert Named to Business Insurance’s 2025 Top 100 Brokers
Recognized nationally for strong growth and client dedication, Seubert celebrates ranking among top U.S. brokers.
Reaping the Health Benefits of Gardening
Home gardening is growing, led by younger generations, despite overall declines in time and expansion plans, says the Axiom Gardening Outlook Study.
Integrative MSK Care: A Roundtable on Clinical Excellence & Sustainable Cost Strategies
Musculoskeletal (MSK) conditions remain one of the most costly and complex challenges in employer-sponsored health plans—driving not only medical expenses, but also productivity losses, disability claims, and diminished quality of life.